| 000 | 01591 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515051308.0 | ||
| 264 | 0 | _c20070607 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0172-780X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatal, Jaroslav | |
| 245 | 0 | 0 |
_aExperimental approaches to studies on drug metabolism and drug interactions in man: interaction of acyclic nucleoside phosphonates with human liver cytochromes P450 and flavin-containing monooxygenase 3. _h[electronic resource] |
| 260 |
_bNeuro endocrinology letters _cDec 2006 |
||
| 300 |
_a27-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBacteria _xultrastructure |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMetabolic Detoxication, Phase I |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xgenetics |
| 650 | 0 | 4 |
_aOrganophosphonates _xpharmacokinetics |
| 650 | 0 | 4 |
_aOxygenases _xmetabolism |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aTenofovir |
| 650 | 0 | 4 | _aTransformation, Bacterial |
| 700 | 1 | _aOrság, Jirí | |
| 700 | 1 | _aNekvindová, Jana | |
| 700 | 1 | _aAnzenbacherová, Eva | |
| 700 | 1 | _aVeinlichová, Alena | |
| 700 | 1 | _aAnzenbacher, Pavel | |
| 700 | 1 | _aZídek, Zdenek | |
| 700 | 1 | _aHolý, Antonín | |
| 773 | 0 |
_tNeuro endocrinology letters _gvol. 27 Suppl 2 _gp. 27-30 |
|
| 999 |
_c16728581 _d16728581 |
||